-+ 0.00%
-+ 0.00%
-+ 0.00%

Goli Pharmaceuticals announced that the US Phase II study on ASC30 treatment of type 2 diabetes achieved positive top-line results.

Zhitongcaijing·10/29/2026 00:17:04
Listen to the news
Goli Pharmaceuticals announced that the US Phase II study on ASC30 treatment of type 2 diabetes achieved positive top-line results.